Company intelligence / Profile preview

The WhiteOak

Raleigh, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

WhiteOak Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for dermatological and inflammatory conditions. The company leverages its expertise in formulation science to improve the delivery and efficacy of established therapeutic agents. WhiteOak's portfolio primarily includes topical treatments designed to address unmet needs in skin health, such as dermatitis and psoriasis. By focusing on patient-centric solutions, the company aims to provide high-quality, accessible medications that enhance clinical outcomes in the specialty dermatology market.

Therapeutic areas: Dermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on The WhiteOak.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The WhiteOak.

Explore the full profile